Company Overview
| Stock Name | 德視佳國際眼科有限公司 |
|---|---|
| Stock Code | 01846 |
| Company Full Name | 德視佳國際眼科有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於德國、丹麥及中國提供視力矯正服務。 |
| Listing Date | 2019-10-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港銅鑼灣羅素街2-4號2000年廣場 3樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://euroeyes.com/ |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 7.50 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 178,515,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 11.0 |
|---|---|
| First Day Open | HK$ 14.2 |
| First Day Change | 46.67% |
| First Day Volume | 99111000.0 |
| First Day Turnover | 1248930000.0 |
Use of Proceeds
| Use of Proceeds | 1、約210.7百萬港元(占估計所得款項凈額總數的約40.0%)用于在中國主要城市(包括成都和重慶)設立診所； 2、約173.8百萬港元(占估計所得款項凈額總數的約33.0%)用于可能收購歐洲的診所集團； 3、約89.5百萬港元(占估計所得款項凈額總數的約17.0%)用于加大我們的營銷力度； 4、約52.7百萬港元(占估計所得款項凈額總數的約10.0%)用于我們的營運資金及用于一般企業用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
中银国际亚洲有限公司 CE AET863
Overall Coordinators (1)
中银国际亚洲有限公司 CE AET863
Joint Bookrunners (3)
中银国际亚洲有限公司 CE AET863
中信建投（国际）融资有限公司 CE BAU112
复星国际证券有限公司 CE AAF432
Joint Lead Managers (3)
中银国际亚洲有限公司 CE AET863
中信建投（国际）融资有限公司 CE BAU112
复星国际证券有限公司 CE AAF432
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | Jorn Slot Jorgensen |
|---|---|
| Company Secretary | 何家穎 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Jorn Slot Jorgensen(54.50%) |
|---|
